E-Learning Center
Join Our Network
OncoFacts

QUICK POLL

Which of the following statements regarding smoldering multiple myeloma (SMM) is NOT correct?






Follow Imedex on Twitter

Hematology Highlights: News from the 50th Annual Hematology Meeting


Register Now

Hematology Highlights: News from the 50th Annual Hematology Meeting

January 24, 2009

Chicago, Illinois, United States

Westin River North

Continuing Medical Education

Imedex, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians. Imedex, LLC designates this educational activity for a maximum 6.0 of AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Who Should Attend

This educational activity is designed for hematologists/oncologists, internists, and other healthcare professionals (physician assistants, nurses, nurse practitioners, and pharmacists) with an interest and/or involvement in hematologic malignancies.

Objectives

After successful completion of this course, participants should be able to:

  • Analyze emerging data on multiple hematologic malignancies and benign abnormalities toward improved patient outcomes
  • Explain the limitations and benefits of new and emerging therapies for the treatment of patients with benign and malignant
  • Incorporate emerging data into the clinical management of patients with benign and malignant hematologic conditions
  • Discuss ways in which current clinical practice should be modified based on the latest advances in hematology

 

Rafat Abonour, MD
Indiana University Medical Center
Indianapolis, Indiana

James O. Armitage, MD
University of Nebraska Medical Center
Omaha, Nebraska

William I. Bensinger, MD
Fred Hutchinson Cancer Research Center
Seattle, Washington

Morton Coleman, MD
Weill Medical College of Cornell University
New York, New York

Larry D. Cripe, MD
Indiana University
Melvin and Bren Simon Cancer Center
Indianapolis, Indiana

Asher A. Chanan-Khan, MD
Roswell Park Cancer Institute
Buffalo, New York

Myron S. Czuczman, MD
Roswell Park Cancer Institute
Buffalo, New York

Marcel P. DeVetten, MD
University of Nebraska Medical Center
Omaha, Nebraska

John F. DiPersio, MD, PhD
Washington University School of Medicine
St. Louis, Missouri

Alessandra Ferrajoli, MD
M. D. Anderson Cancer Center
Houston, Texas

Rafael Fonseca, MD
Mayo Clinic
Scottsdale, Arizona

Peter L. Greenberg, MD
Stanford Comprehensive Cancer Center
Stanford, California

Ronald Hoffman, MD
Mt. Sinai School of Medicine
New York, New York

Sagar Lonial, MD
Emory University Winship Cancer Institute
Atlanta, Georgia

Ruben A. Mesa MD
Mayo Clinic
Rochester, Minnesota

Nikhil C. Munshi, MD
Dana-Farber Cancer Institute
Boston, Massachusetts

Stephen D. Nimer, MD
Memorial Sloan-Kettering Cancer Center
New York, New York

Owen A. O’Connor, MD, PhD
Columbia University Herbert Irving Comprehensive Cancer Center
New York, New York

Carol S. Portlock, MD
Memorial Sloan-Kettering Cancer Center
New York, New York

Jerry P. Radich, MD
Fred Hutchinson Cancer Research Center
Seattle, Washington

Paul G. Richardson, MD
Dana-Farber Cancer Institute
New York, New York

Gail J. Roboz, MD
Weill Medical College of Cornell University
New York, New York

Seema Singhal, MD
Northwestern University
Chicago, Illinois

Steven P. Treon, MD, PhD
Dana-Farber Cancer Institute
Boston, Massachusetts

 

** This is a draft agenda. Final topics to be selected based on abstracts released during the 2008 ASH® Meeting.

 

7:00 am
Breakfast and registration

8:00 am
Welcome and introduction

8:15 am
Multiple Myeloma

9:20 am
Chronic Lymphocytic Leukemia (CLL)

10:00 am
Break

10:30 am
Myelodysplastic Syndromes (MDS)

11:15 am
Chronic Myelogenous Leukemia (CML)

11:55 am
Lunch

1:15 pm
Myeloproliferative Disorders (MPD)

1:55 pm
Lymphomas

3:00 pm
Break

3:20 pm
Acute Leukemia

4:00 pm
Adjourn

 

Register Now



Registration Fees

Physicians . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 99.00

Nurses/Residents/Students*. . . . . . . . . . . . . . . .$ 45.00
*proof of eligibility must accompany registration; cannot be combined with any other discounts

Pharmaceutical Industry. . . . . . . . . . . . . . . . . . .$175.00



To Register: You may register online up to 5 business days before the meeting atwww.imedex.com, by calling Imedex at+1 (678) 242 0906 or by returning the registration form in this program by mail or fax. If you mail the form, please keep a copy for your records. Registration confirmations will be issued before the meeting.

Payment: To pre-register, registration and payment must be received no later than 5 business days before the meeting. Please register onsite after this date. Contact Imedex at +1 (678) 242 0906 or visit our website at www.imedex.com to ensure the course is being held as scheduled and to confirm that the meeting is not full. Registration fees must be remitted by credit card or check. Checks should be payable to Imedex, LLC. Attendee is not registered until full payment is received.

Registration Fee Inclusions: Registration fees include admittance to all scientific sessions, conference materials, processing of certificates of attendance or continuing medical education, and all event functions as specified in the agenda.

Cancellation: For registration fees to be refunded, written notice of cancellation must be received at meetings@imedex.com no later than 5 business days before the meeting.The amount of registration fees remitted, minus a $25 administrative charge, will be refunded after the conference. Substitutions are accepted with written notification. No refunds will be made if notice is received after 5 business days before the meeting.

Imedex does not accept responsibility for covering travel, accommodation or any other costs incurred by registrants in the rare event that this meeting should be canceled for any reason. Every effort will be made to give reasonable notice in the event of cancellation. The event agenda is subject to change without notice.

Crowne Plaza Times Square Manhattan
January 10, 2009
1605 Broadway New York, New York 10019
+1 800 243 6969 (toll-free from USA only)
Rate: $279 +13.375% tax +$2 per room
Hotel Registration deadline: December 22, 2008

 

Westin Chicago River North
January 24, 2009
320 North Dearborn Street Chicago, Illinois 60610
+1 800 937 8461 (toll-free from USA /Canada only)
Rate: S-$159/D-$189 + 15.4% tax; $30/night for extra person
Hotel Registration deadline: January 8, 2009

 

Palace Hotel
February 7, 2009
2 New Montgomery Street San Francisco, California 94105
+1 888 627 7196 (toll-free)
Rate: $229 + 14.065% tax
Hotel Registration deadline: January 14, 2009

 

Crowne Plaza Times Square Manhattan
February 7, 2009
1605 Broadway New York, New York 10019
+1 800 243 6969 (toll-free from USA only)
Rate: $279 +13.375% tax +$2 per room
Hotel Registration deadline: January 6, 2009

 

For the convenience of attendees, a limited number of rooms have been reserved at the conference hotel along with the discounted rate and cut-off date as noted above plus tax. This rate is not guaranteed outside the conference dates. To reserve your room please contact the hotel reservations department at the phone number above. To receive the group rate, callers must identify themselves as being with the 2009 Hematology Highlights Meeting. Reservation requests received after the hotel cutoff date as noted above may not be guaranteed the group rate.

Series Chair
James Epstein, MD
Senior Medical Adviser
Imedex, LLC
Alpharetta, Georgia

 

ORGANIZER

Imedex
4325 Alexander Drive
Alpharetta, GA 30022-3740 USA
Tel.: +1 (770) 751 7332
Fax: +1 (770) 751 7334
Email: meetings@imedex.com
Web: www.imedex.com

PDF Announcement

GOLD

celgene

Millennium Pharmaceuticals, Inc.

 

SILVER
genentech

 

BRONZE

celgene

Genentech BioOncology
& Biogen Idec

 

CORPORATE

genentech
genentech

 

 

Several options are available to companies interested in supporting this Congress. For more information, please contact Imedex at +1(770) 751 7332, or by email at cme@imedex.com.